Correlation Between Minimum Apparent Diffusion Coefficient Values and the Histological Grade of Breast Invasive Ductal Carcinoma

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Jun 1

PMID 29849809

Citations 5

Authors

Suhong Zhao

Weihua Guo

Ru Tan

Peipei Chen

Zhaohua Li

Fengguo Sun

Guangrui Shao

Affiliations

Soon will be listed here.

Abstract

The present study aimed to investigate the correlation between the minimum apparent diffusion coefficient (ADC) value and the histological grade of breast invasive ductal carcinoma (IDC). In total, 129 pathologically verified lesions that were subjected to dynamic breast magnetic resonance imaging and diffusion weighted imaging prior to biopsy were included. The ADC value was calculated and its correlation with the tumor histological grade was investigated. Tumors of lower grades demonstrated significantly higher ADC values as compared with tumors of higher grades (F=33.49; P<0.01). The mean ADC values for IDC of grades I, II and III were (1.14±0.11)×10, (0.99±0.12)×10 and (0.86±0.13)×10 mm/sec, respectively. Statistically significant differences were detected in the mean ADC value between tumors of grades II and III (P<0.01), as well as between tumors of grades I and II (P<0.01). In addition, the mean ADC values for the less aggressive (grades I and II) and more aggressive (grade III) groups were (1.01±0.13)×10 and (0.86±0.13)×10 mm/sec, respectively (t=5.76, P<0.01). In conclusion, these data indicated that the ADC value was correlated with the IDC histological grade, and lower ADC values were associated with a higher histological grade and more aggressiveness. Thus, the ADC value may be considered as a promising prognostic parameter in identifying tumor aggressiveness.

Citing Articles

Relationship Between Metabolic Activity, Cellularity, Histopathological Features of Primary Tumors and Distant Metastatic Potential in Breast Cancer.

Aydos U, Gulbahar Ates S, Kurukahvecioglu O, Akdemir U, Uyar Gocun P, Atay L Mol Imaging Radionucl Ther. 2023; 32(3):195-205.

PMID: 37870280 PMC: 10600550. DOI: 10.4274/mirt.galenos.2022.60024.

Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.

Chen P, Zhao S, Guo W, Shao G Quant Imaging Med Surg. 2023; 13(8):4816-4825.

PMID: 37581065 PMC: 10423352. DOI: 10.21037/qims-22-1318.

Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors.

Xie Y, Zhang S, Liu X, Huang X, Zhou Q, Luo Y Jpn J Radiol. 2022; 40(8):823-830.

PMID: 35284998 DOI: 10.1007/s11604-022-01262-5.

On the Additional Information Provided by 3T-MRI ADC in Predicting Tumor Cellularity and Microscopic Behavior.

Santucci D, Faiella E, Calabrese A, Zobel B, Ascione A, Cerbelli B Cancers (Basel). 2021; 13(20).

PMID: 34680316 PMC: 8534264. DOI: 10.3390/cancers13205167.

Effectiveness of ADC Difference Value on Pre-neoadjuvant Chemotherapy MRI for Response Evaluation of Breast Cancer.

Choi B Technol Cancer Res Treat. 2021; 20:15330338211039129.

PMID: 34519583 PMC: 8445528. DOI: 10.1177/15330338211039129.

References

Cabuk G, Nass Duce M, Ozgur A, Apaydin F, Polat A, Orekici G . The diagnostic value of diffusion-weighted imaging and the apparent diffusion coefficient values in the differentiation of benign and malignant breast lesions. J Med Imaging Radiat Oncol. 2015; 59(2):141-8. DOI: 10.1111/1754-9485.12273. View

Bammer R . Basic principles of diffusion-weighted imaging. Eur J Radiol. 2003; 45(3):169-84. DOI: 10.1016/s0720-048x(02)00303-0. View

Elston C . Classification and grading of invasive breast carcinoma. Verh Dtsch Ges Pathol. 2007; 89:35-44. View

Mori N, Ota H, Mugikura S, Takasawa C, Tominaga J, Ishida T . Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters. Eur Radiol. 2013; 23(10):2705-12. DOI: 10.1007/s00330-013-2902-2. View

Sinha S, Sinha U, DeBruhl N, Bassett L . In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002; 15(6):693-704. DOI: 10.1002/jmri.10116. View

Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C . Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol. 2007; 17(10):2646-55. DOI: 10.1007/s00330-007-0621-2. View

Kato F, Kudo K, Yamashita H, Wang J, Hosoda M, Hatanaka K . Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI. Eur J Radiol. 2016; 85(1):96-102. DOI: 10.1016/j.ejrad.2015.10.018. View

Hosseinzadeh K, Schwarz S . Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging. 2004; 20(4):654-61. DOI: 10.1002/jmri.20159. View

Zhao J, Guan H, Li M, Gu H, Qin J, Wu X . Significance of the ADC ratio in the differential diagnosis of breast lesions. Acta Radiol. 2015; 57(4):422-9. DOI: 10.1177/0284185115590286. View

10.

Costantini M, Belli P, Rinaldi P, Bufi E, Giardina G, Franceschini G . Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clin Radiol. 2010; 65(12):1005-12. DOI: 10.1016/j.crad.2010.07.008. View

11.

Byun B, Noh W, Lim I, Lee S, Cho A, Park J . A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast. Ann Nucl Med. 2013; 27(8):720-8. DOI: 10.1007/s12149-013-0737-1. View

12.

Guo Y, Cai Y, Cai Z, An N, Ma L, Mahankali S . Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging. 2002; 16(2):172-8. DOI: 10.1002/jmri.10140. View

13.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B . Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008; 10(4):R65. PMC: 2575538. DOI: 10.1186/bcr2124. View

14.

Elston C, Ellis I . Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-10. DOI: 10.1111/j.1365-2559.1991.tb00229.x. View

15.

Park S, Choi H, Hahn S . Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla. J Magn Reson Imaging. 2013; 41(1):175-82. DOI: 10.1002/jmri.24519. View

16.

Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K . ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005; 4(1):35-42. DOI: 10.2463/mrms.4.35. View

17.

Durando M, Gennaro L, Cho G, Giri D, Gnanasigamani M, Patil S . Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Eur J Radiol. 2016; 85(9):1651-8. PMC: 5505563. DOI: 10.1016/j.ejrad.2016.06.019. View

18.

Belli P, Costantini M, Bufi E, Magistrelli A, La Torre G, BONOMO L . Diffusion-weighted imaging in breast lesion evaluation. Radiol Med. 2009; 115(1):51-69. DOI: 10.1007/s11547-009-0430-6. View

19.

Shin H, Kim S, Lee H, Gong G, Baek S, Chae E . Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer. NMR Biomed. 2016; 29(8):1070-8. DOI: 10.1002/nbm.3571. View

20.

Hirano M, Satake H, Ishigaki S, Ikeda M, Kawai H, Naganawa S . Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. AJR Am J Roentgenol. 2012; 198(3):717-22. DOI: 10.2214/AJR.11.7093. View